KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other Non-Current Assets: 2017-2025

Historic Other Non-Current Assets for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $530.0 million.

  • Moderna's Other Non-Current Assets fell 4.68% to $530.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $530.0 million, marking a year-over-year decrease of 4.68%. This contributed to the annual value of $594.0 million for FY2024, which is 22.45% down from last year.
  • Per Moderna's latest filing, its Other Non-Current Assets stood at $530.0 million for Q3 2025, which was down 2.93% from $546.0 million recorded in Q2 2025.
  • Moderna's 5-year Other Non-Current Assets high stood at $1.3 billion for Q2 2023, and its period low was $11.0 million during Q1 2021.
  • Its 3-year average for Other Non-Current Assets is $723.1 million, with a median of $641.0 million in 2024.
  • Per our database at Business Quant, Moderna's Other Non-Current Assets spiked by 2,047.83% in 2022 and then plummeted by 50.31% in 2024.
  • Quarterly analysis of 5 years shows Moderna's Other Non-Current Assets stood at $46.0 million in 2021, then surged by 2,047.83% to $988.0 million in 2022, then declined by 22.47% to $766.0 million in 2023, then fell by 22.45% to $594.0 million in 2024, then dropped by 4.68% to $530.0 million in 2025.
  • Its Other Non-Current Assets was $530.0 million in Q3 2025, compared to $546.0 million in Q2 2025 and $556.0 million in Q1 2025.